Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
EQT snaps up VetPartners in $1.4bn deal
Swedish private equity firm EQT Partners is poised to sign on the dotted line to acquire one of Australia’s largest veterinary chains, VetPartners. Street Talk can reveal EQT dealmakers, Frank Heckes and David Forde, have agreed terms with sell-side adviser Jefferies...
BC Partners and Pollen Street-backed Shawbrook Eye $740m Metro Bank Deal
British specialist lender Shawbrook made an offer for rival Co-op Bank and is weighing a fresh bid for embattled Metro Bank (MTRO.L), people familiar with the matter told Reuters on Sunday. Shawbrook, backed by private equity groups BC Partners and Pollen...
Appian Capital Closes $2.06bn Fund III, Biggest Mining PE Fund
Appian Capital Advisory LLP, the investment advisor to long-term value focused private capital funds that invest solely in mining and mining related companies, announces the final close of its third fund ("Fund III"). Fund III was heavily oversubscribed despite...